Platelet inhibition with the glycoprotein IIb/IIIa receptor antagonist Lamifiban in high risk patient subsets: Studies to determine the correlation between platelet-mediated prothrombotic activity and clinical risk Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • October 21, 1997